143 related articles for article (PubMed ID: 29511683)
1. Circulating CD3
Lee SE; Lim JY; Ryu DB; Kim TW; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Min CK
Biomed Res Int; 2018; 2018():5097325. PubMed ID: 29511683
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of pre-transplant circulating CD3
Kim TW; Lee SE; Lim JY; Ryu DB; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Min CK
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27910184
[TBL] [Abstract][Full Text] [Related]
3. Low frequency of CD3
Lee SE; Lim JY; Ryu DB; Kim TW; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min CK
Ann Hematol; 2018 Nov; 97(11):2163-2171. PubMed ID: 29938309
[TBL] [Abstract][Full Text] [Related]
4. CD161(+) T cells as predictive markers for acute graft-versus-host disease.
Lee SE; Lim JY; Yoon JH; Shin SH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Min CK
Biol Blood Marrow Transplant; 2015 Mar; 21(3):421-8. PubMed ID: 25543092
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte subset analysis for the assessment of treatment-related complications after autologous stem cell transplantation in multiple myeloma.
Lee SE; Yahng SA; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Min CK
Cytotherapy; 2012 Apr; 14(4):505-12. PubMed ID: 22309319
[TBL] [Abstract][Full Text] [Related]
6. Depletion of pro-inflammatory CD161(+) double negative (CD3(+)CD4(-)CD8(-)) T cells in AIDS patients is ameliorated by expansion of the γδ T cell population.
Singleterry WL; Henderson H; Cruse JM
Exp Mol Pathol; 2012 Feb; 92(1):155-9. PubMed ID: 22100877
[TBL] [Abstract][Full Text] [Related]
7. A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation.
Hari P; Aljitawi OS; Arce-Lara C; Nath R; Callander N; Bhat G; Allen LF; Stockerl-Goldstein K
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2100-2105. PubMed ID: 26327631
[TBL] [Abstract][Full Text] [Related]
8. Adoptive cellular therapy using cells enriched for NKG2D+CD3+CD8+T cells after autologous transplantation for myeloma.
Meehan KR; Talebian L; Tosteson TD; Hill JM; Szczepiorkowski Z; Sentman CL; Ernstoff MS
Biol Blood Marrow Transplant; 2013 Jan; 19(1):129-37. PubMed ID: 22975165
[TBL] [Abstract][Full Text] [Related]
9. T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple Myeloma.
Lucas F; Pennell M; Huang Y; Benson DM; Efebera YA; Chaudhry M; Hughes T; Woyach JA; Byrd JC; Zhang S; Jones D; Guan X; Burd CE; Rosko AE
Biol Blood Marrow Transplant; 2020 Jan; 26(1):7-15. PubMed ID: 31445183
[TBL] [Abstract][Full Text] [Related]
10. Increased frequency of CD4+ cells expressing CD161 in cancer patients.
Iliopoulou EG; Karamouzis MV; Missitzis I; Ardavanis A; Sotiriadou NN; Baxevanis CN; Rigatos G; Papamichail M; Perez SA
Clin Cancer Res; 2006 Dec; 12(23):6901-9. PubMed ID: 17145807
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation.
Massoud R; Assi R; Fares E; Haffar B; Charafeddine M; Kreidieh N; Mahfouz R; Kanj SS; El Zakhem A; Kharfan-Dabaja M; Bazarbachi A; El Cheikh J
J Clin Virol; 2017 Oct; 95():36-41. PubMed ID: 28843110
[TBL] [Abstract][Full Text] [Related]
12. Impact of Aging on the Frequency, Phenotype, and Function of CD161-Expressing T Cells.
van der Geest KSM; Kroesen BJ; Horst G; Abdulahad WH; Brouwer E; Boots AMH
Front Immunol; 2018; 9():752. PubMed ID: 29725326
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study.
Marchesi F; Pimpinelli F; Dessanti ML; Gumenyuk S; Palombi F; Pisani F; Romano A; Spadea A; Maschio M; Ensoli F; Mengarelli A
Transpl Infect Dis; 2014 Dec; 16(6):1032-8. PubMed ID: 25369809
[TBL] [Abstract][Full Text] [Related]
14. The choice of multiple myeloma induction therapy affects the frequency and severity of oral mucositis after melphalan-based autologous stem cell transplantation.
Fleming S; Harrison SJ; Blombery P; Joyce T; Stokes K; Seymour JF; Prince HM; Ritchie D
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):291-6. PubMed ID: 24629850
[TBL] [Abstract][Full Text] [Related]
15. Association between CMV and Invasive Fungal Infections After Autologous Stem Cell Transplant in Lymphoproliferative Malignancies: Opportunistic Partnership or Cause-Effect Relationship?
Marchesi F; Pimpinelli F; Di Domenico EG; Renzi D; Gallo MT; Regazzo G; Rizzo MG; Gumenyuk S; Toma L; Marino M; Cordone I; Cantonetti M; Liberati AM; Montanaro M; Ceribelli A; Prignano G; Palombi F; Romano A; Papa E; Pisani F; Spadea A; Arcese W; Ensoli F; Mengarelli A
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30893777
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the CD161-expressing cell quantities and CD161 expression levels in peripheral blood natural killer and T cells of systemic lupus erythematosus patients.
Lin YL; Lin SC
Clin Exp Med; 2017 Feb; 17(1):101-109. PubMed ID: 26590595
[TBL] [Abstract][Full Text] [Related]
17. Antigen-specific T-cell immunity in multiple myeloma patients is restored following high-dose therapy: implications for timing of vaccination.
Svane IM; Nikolajsen K; Johnsen HE
Scand J Immunol; 2007 Oct; 66(4):465-75. PubMed ID: 17850592
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome.
Zhao L; Nocturne G; Haskett S; Boudaoud S; Lazure T; Le Pajolec C; Mariette X; Mingueneau M; Banerjee D
Rheumatology (Oxford); 2017 Feb; 56(2):303-312. PubMed ID: 27803305
[TBL] [Abstract][Full Text] [Related]
19. Multiple myeloma patients in long-term complete response after autologous stem cell transplantation express a particular immune signature with potential prognostic implication.
Arteche-López A; Kreutzman A; Alegre A; Sanz Martín P; Aguado B; González-Pardo M; Espiño M; Villar LM; García Belmonte D; de la Cámara R; Muñoz-Calleja C
Bone Marrow Transplant; 2017 Jun; 52(6):832-838. PubMed ID: 28368375
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Comorbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Undergoing Outpatient Autologous Stem Cell Transplantation.
Obiozor C; Subramaniam DP; Divine C; Shune L; Singh AK; Lin TL; Abhyankar S; Chen GJ; McGuirk J; Ganguly S
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1641-1645. PubMed ID: 28603071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]